TSCAN THERAPEUTICS INC
TCRXNASDAQ🏆 #4788 by market capEarnings Nov 10US Equity
$0.32▼ $0.02 (−6.51%)
Market closed · at closeTrack TCRX
Get earnings, price moves & breaking news on Telegram
24h▼ 6.5%
7d▼ 12.1%
14d▼ 3.0%
30d▼ 56.1%
ytd▼ 67.9%
1y▼ 81.9%
🏦Market Cap
$20M
Small Cap
📈Revenue Growth (YoY)
+266.6%
High Growth
📊Gross Margin
90.3%
High
💵FCF Margin
-1665.6%
Thin
⚖️P/S Ratio
2.7x
Cheap
Otter Score
72
Fair
TSCAN THERAPEUTICS INC
TCRXAnalyst Ratings
Price
$0.3200
Total
8
Raised
0
Lowered
4
Avg PT
$1.00
H / L
$1 / $1
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2026-09-08 | — | — |
Wedbush | Downgraded | Outperform → Neutral | 2026-09-03 | $1.00 | +212.50% |
Needham | Downgraded | Buy → Hold | 2026-09-02 | — | — |
BTIG | Downgraded | Buy → Neutral | 2025-11-04 | $12.00 | +3650.00% |
Barclays | Reiterated | Overweight | 2025-03-07 | $3.00 | +837.50% |
Cowen & Co. | Reiterated | Outperform | 2021-08-13 | — | — |
Morgan Stanley | Reiterated | Overweight | 2021-08-10 | — | — |
Jefferies | Reiterated | Buy | 2021-08-10 | — | — |
Institution
HC Wainwright & Co.
Downgraded · Buy → Neutral · 2026-09-08
—
—
Wedbush
Downgraded · Outperform → Neutral · 2026-09-03
$1.00
+212.50%
Needham
Downgraded · Buy → Hold · 2026-09-02
—
—
BTIG
Downgraded · Buy → Neutral · 2025-11-04
$12.00
+3650.00%
Barclays
Reiterated · Overweight · 2025-03-07
$3.00
+837.50%
Cowen & Co.
Reiterated · Outperform · 2021-08-13
—
—
Morgan Stanley
Reiterated · Overweight · 2021-08-10
—
—
Jefferies
Reiterated · Buy · 2021-08-10
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space